Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H18N4O4PS.H2O4P |
| Molecular Weight | 442.322 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)([O-])=O.CC1=C(CCOP(O)(O)=O)SC=[N+]1CC2=CN=C(C)N=C2N
InChI
InChIKey=CUWOKLAYADTBBR-UHFFFAOYSA-N
InChI=1S/C12H17N4O4PS.H3O4P/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13;1-5(2,3)4/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19);(H3,1,2,3,4)
Monophosphothiamine is thiamine derivative used for the treatment of neuritis, polyneuritis, asthenic conditions (weakness), as an additional remedy for chronic blood circulation insufficiency, chronic gastritis accompanied by motor and secretory disorders functions of the stomach. Monophosphothiamine underwent metabolic phosphorylation to active metabolite thiamine pyrophosphate, that acts as a coenzyme in the different metabolic process.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rlsnet.ru/tn_index_id_5374.htm
0,01 - 0.03 g 3-4 times a day (after food) for 3-4 weeks.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
JS7TVM93UY
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY | |||
|
100000086022
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY | |||
|
3033991
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY | |||
|
SUB22326
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY | |||
|
DTXSID20212906
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY | |||
|
635-97-2
Created by
admin on Mon Mar 31 22:39:32 GMT 2025 , Edited by admin on Mon Mar 31 22:39:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD